Concurrent Technologies
Ticker: CNC Exchange: AIM concurrent.tech/

From medical advancements to cutting-edge aerospace, Concurrent Technologies' high performance embedded computer solutions are the backbone of critical systems across various industries. The group delivers these solutions to operate flawlessly in even the harshest of environments. 

Capitalising on a material growth opportunity

Concurrent Technologies has continued its excellent growth record of recent years by reporting a strong H1 26 performance with revenue up 10%YoY to £23.2m and EBITDA (adj.) of £4.8m +20%YoY, and a 20.7% margin (H1 25, 18.8%). Order intake stood out as particularly strong, up 1.1x YoY at £46.9m (H1 25, £22.3m), i.e. equivalent to the full year FY25.  

Furthermore, progress in converting design wins into production programmes indicates that the estimated lifetime value in the Products and Systems operations stands at £129m.  

At the time of reporting, the Group stands with an order book of over £68m, with continued growth momentum anticipating ‘an exceptionally busy fourth quarter’. We expect H2 (adj.) EBIT to be c.63% above H1 (vs H2 25: 48% above).  

We initiate coverage with a Fair Value of 328p/share that equates to a FY28 multiple of 18.5x, which still compares favourably to the current average of defence peers and of direct competitors.

 

 

 
Download as a PDF file
26810392321 - concurrent-technologies
Return to Concurrent Technologies

Register to be first

Get research on the companies that interest you straight to your inbox

Register For Updates